Abiopharma

News list

Coughlin Elizabeth Reid 🟢 acquired 6.8K shares of AXON ENTERPRISE, INC. (AXON) Transaction Date: Aug 16, 2026 | Filing ID: 057442

Full text

News bot Aug. 17, 2026, 9:19 p.m.
🔍 Coughlin Elizabeth Reid (Executive)

Company: AXON ENTERPRISE, INC. (AXON)

Report Date: 2026-08-16
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 6,818
Detailed Transactions and Holdings:
- Acquired 6,818 shares of Common Stock (Direct)
  Date: 2026-08-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 40,841.83 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on December 1, 2026, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes.